Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$341K Buy
1,772
+169
+11% +$32.4K 0.08% 141
2019
Q2
$295K Sell
1,603
-300
-16% -$53.7K 0.07% 147
2019
Q1
$362K Buy
1,903
+800
+73% +$153K 0.1% 136
2018
Q4
$215K Buy
+1,103
New +$215K 0.08% 134

Other funds holding AMGN

Capital One Investing's AMGN Position: Q3 2019 in Review

Capital One Investing increased its Amgen (AMGN) stake by 11% in Q3 2019, buying an estimated $32.4K and bringing the position to 1,772 shares worth $341K. The position accounts for 0.08% of the portfolio, ranked #141.

Capital One Investing first reported a position in AMGN in Q4 2018 and has held it in 4 quarters since. The position peaked at $362K in Q1 2019. 1,884 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Capital One Investing held 1,772 shares of Amgen worth $341K as of Q3 2019.
  • Capital One Investing bought 169 Amgen shares in Q3 2019, an estimated $32.4K.
  • Amgen made up 0.08% of Capital One Investing's portfolio in Q3 2019, its #141 holding.
  • Capital One Investing first reported a position in Amgen in Q4 2018 and has held it in 4 quarters since.
  • Capital One Investing's Amgen position peaked at $362K in Q1 2019.
  • 1,884 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Capital One Investing's 13F filing for Q3 2019, filed 14 Nov 2019.